Clinical Trends in IVF in Daily Practice

Abstract

In vitro fertilization (IVF) is a cornerstone of assisted reproductive technology (ART), offering hope to couples experiencing infertility. In recent years, clinical trends in IVF have evolved dramatically, influenced by advances in laboratory techniques, patient-tailored protocols, and emerging evidence-based guidelines. This review synthesizes current epidemiological data, elucidates underlying pathophysiological mechanisms, highlights relevant risk factors, and discusses the latest advances in diagnosis and management. Practical implications for daily practice and guideline-based recommendations are emphasized to inform clinicians and healthcare professionals engaged in reproductive medicine.

Introduction

The landscape of infertility management has been transformed by the advent and evolution of IVF, which now represents a mainstay option for patients with diverse etiologies of subfertility. Globally, the demand for IVF is increasing, driven by delayed childbearing, rising prevalence of reproductive health disorders, and improved access to ART services. Clinicians must remain abreast of emerging trends and evidence to optimize outcomes, minimize risks, and ensure patient-centered care in daily IVF practice.

Epidemiology / Disease Burden

Infertility affects approximately 8-12% of couples worldwide, with a significant psychosocial and economic impact. According to the World Health Organization, the global use of ART, particularly IVF, has risen steadily, with millions of cycles performed annually. The incidence of infertility is influenced by factors such as advanced maternal age, obesity, environmental exposures, and rising prevalence of conditions like polycystic ovary syndrome (PCOS) and endometriosis. Demographic shifts, including delayed marriage and childbearing, have contributed to increased demand for IVF services, particularly in urban and developed settings.

Pathophysiology

The pathophysiological mechanisms underlying infertility are multifaceted, encompassing female factors (ovulatory dysfunction, tubal pathology, endometriosis), male factors (oligospermia, asthenospermia), and unexplained causes. IVF bypasses several natural barriers to conception by facilitating controlled ovarian stimulation, retrieval of oocytes, fertilization ex vivo, and embryo transfer. Innovations such as intracytoplasmic sperm injection (ICSI) address severe male factor infertility, while preimplantation genetic testing (PGT) allows for selection of euploid embryos, reducing miscarriage risk and improving live birth rates.

Risk Factors

Key risk factors influencing IVF outcomes include advanced maternal age, diminished ovarian reserve, obesity, smoking, and comorbid conditions such as thyroid dysfunction or diabetes. Male age and sperm quality also play critical roles. Iatrogenic factors, such as repeated ovarian stimulation, can increase the risk of ovarian hyperstimulation syndrome (OHSS) and other complications. Recognizing and modifying modifiable risk factors is essential for optimizing IVF success and minimizing adverse events.

Clinical Features

Patients presenting for IVF typically report a history of infertility, often defined as failure to conceive after 12 months of unprotected intercourse. Clinical assessment includes evaluation of menstrual regularity, ovulatory status, tubal patency, and male partner semen analysis. Underlying etiologies may present with specific features, such as hirsutism and anovulation in PCOS, or pelvic pain and dysmenorrhea in endometriosis. Comprehensive history and examination guide individualized diagnostic and therapeutic strategies.

Diagnosis

A thorough diagnostic workup precedes IVF, encompassing assessment of ovarian reserve (anti-Müllerian hormone, antral follicle count), uterine cavity (ultrasound, hysteroscopy), tubal patency (hysterosalpingography), and semen parameters. Genetic screening for chromosomal abnormalities or single-gene disorders may be indicated in select couples. The use of advanced technologies, such as time-lapse embryo imaging and PGT, enables more precise embryo selection and improved implantation rates.

Treatment & Management

IVF protocols are tailored to individual patient characteristics and underlying etiologies. Controlled ovarian stimulation is achieved using gonadotropins, with or without adjunctive agents such as GnRH agonists or antagonists. Oocyte retrieval is performed transvaginally under ultrasound guidance, followed by fertilization in vitro. Embryo transfer is scheduled based on embryo development, with luteal phase support provided by progesterone. Adjuncts such as ICSI, assisted hatching, and cryopreservation expand treatment options. Management of complications, including OHSS and multiple gestations, requires vigilance and prompt intervention.

Recent Advances / Emerging Therapies

Several recent advances are shaping the future of IVF. The adoption of mild stimulation protocols, freeze-all strategies, and single embryo transfer (SET) have reduced complications and improved cumulative live birth rates. Innovations in embryo culture, such as time-lapse imaging and advanced culture media, enhance embryo selection. Preimplantation genetic testing for aneuploidy (PGT-A) and monogenic diseases (PGT-M) are increasingly utilized to improve outcomes, particularly in older women and those with recurrent pregnancy loss. Artificial intelligence applications are emerging in embryo assessment and cycle prediction. The use of novel adjuvants, such as growth hormone or androgen supplementation, remains under investigation.

Guideline Recommendations

Contemporary guidelines from the American Society for Reproductive Medicine (ASRM), European Society of Human Reproduction and Embryology (ESHRE), and other bodies emphasize individualized, evidence-based care. Key recommendations include counseling regarding realistic success rates, minimizing multiple pregnancies through SET, and judicious use of adjuvant therapies. Ovarian reserve testing, male factor assessment, and preconception optimization of health are integral components of care. Regular updates to protocols and patient counseling are essential to reflect evolving evidence and best practice.

Conclusion

IVF practice is undergoing dynamic transformation, driven by advances in technology, improved understanding of reproductive biology, and evolving clinical guidelines. Clinicians must integrate current evidence, patient preferences, and individualized risk assessment to optimize outcomes in daily practice. Ongoing research and innovation will continue to refine IVF protocols, enhance safety, and expand access, ensuring that ART remains at the forefront of reproductive medicine.